Progress in researches on drugs for prostate cancer.
- Author:
Ling-Yan CAO
1
;
He HUANG
;
Jiang-Hong NI
Author Information
1. Department of Pharmaceutic Products, Nanjing General Hospital of Nanjing Command, PLA, Nanjing, Jiangsu 210002, China.
- Publication Type:Journal Article
- MeSH:
Androgen Antagonists;
therapeutic use;
Antineoplastic Agents;
therapeutic use;
Goserelin;
therapeutic use;
Humans;
Male;
Prostatic Neoplasms;
drug therapy;
Sulfonamides;
therapeutic use;
Suramin;
therapeutic use;
Thioxanthenes;
therapeutic use
- From:
National Journal of Andrology
2003;9(9):703-706
- CountryChina
- Language:Chinese
-
Abstract:
In the recent years, researches on drugs for prostate cancer have received more attention than ever before. This article reviews the mechanism and efficacy of such prostate cancer drugs as bicalutamide, medroxyprogesterone acetate, megestrol acetate, flutamide and so on, as well as the clinical data and clinical uses of calcitriol analogue EB1089, SR233377, etc.
